Funder
Pfizer Investment Co. Ltd.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference28 articles.
1. Centers for Disease Control Prevention (CDC) (2014) Acinetobacter in Healthcare Settings. Available online at:
https://www.cdc.gov/hai/organisms/acinetobacter.html
. Accessed 26 Sep 2016
2. Henig O, Weber G, Hoshen MB, Paul M, German L, Neuberger A et al (2015) Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case–control study. Eur J Clin Microbiol 34:2063–2068
3. Djordjevic ZM, Folic MM, Folic ND, Gajovic N, Gajovic O, Jankovic SM (2016) Risk factors for hospital infections caused by carbapanem-resistant Acinetobacter baumannii. J Infect Dev Ctries 10:1073–1080
4. Qureshi ZA, Hittle LE, O’Hara JA, Rivera JI, Syed A, Shields RK et al (2015) Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin Infect Dis 60:1295–1303
5. Ozsurekci Y, Aykac K, Cengiz AB, Basaranoglu ST, Sancak B, Karahan S et al (2017) Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: risk factors and outcome. Diagn Microbiol Infect Dis 87:359–364
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献